United Therapeutics (UTHR) Change in Account Payables (2009 - 2013)

United Therapeutics has disclosed Change in Account Payables across 5 years of filings, most recently posting -$899000.0 for Q2 2013.

• Change in Account Payables for Q2 2013 came in at -$899000.0, down 313.03% year-over-year; the trailing twelve-month figure through Jun 2013 was $562000.0 (up 102.47% YoY), and the FY2012 annual result was -$37.2 million, down 323.38% from the prior year.
• Change in Account Payables came in at -$899000.0 for Q2 2013 at United Therapeutics, down from $119000.0 in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $15.6 million in Q4 2011 to a low of -$39.0 million in Q1 2012.
• The 5-year median for Change in Account Payables is $285500.0 (2011), against an average of -$1.1 million.
• Peak annual rise in Change in Account Payables reached 788.59% in 2012, while the deepest fall reached 533.67% in 2012.
• United Therapeutics' Change in Account Payables stood at -$922000.0 in 2009, then jumped by 611.61% to $4.7 million in 2010, then surged by 231.06% to $15.6 million in 2011, then tumbled by 99.88% to $18000.0 in 2012, then sank by 5094.44% to -$899000.0 in 2013.
• The last three Change in Account Payables figures came in at -$899000.0 (Q2 2013), $119000.0 (Q1 2013), and $18000.0 (Q4 2012), per Business Quant data.